A comprehensive review of Strongyloides stercoralis infection after solid organ and hematopoietic stem cell transplantation.

Strongyloidiasis should be strongly considered among recipients with epidemiologic risk factors for infection, even in the absence of eosinophilia or rash. A policy that provides guidance on pro-active screening is needed, to ensure preventive measures are provided to recipients at increased risk.